Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eprex and Ferinject for Transfusion Prevention in Cardiac Surgery
NCT02210949Phase 4Terminated
- Sponsor
- Catharina Ziekenhuis
- Start
- Aug 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of epoetin alfa, ferric carboxymaltose in anemia, iron deficiency anemia (IDA), sponsored by Catharina Ziekenhuis. Started Aug 2014; status: terminated.
02
Drugs
epoetin alfaferric carboxymaltose
03
Conditions
anemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02210949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02210949.